Trials
Search / Trial NCT06427720

LINC00511/miR-185-3p Axis and miR-301a-3p Markers for Breast Cancer Diagnosis

Launched by AIN SHAMS UNIVERSITY · May 20, 2024

Apply for Trial

Trial Information

Current as of March 14, 2025

Completed

Keywords

Easy Diagnosed Stage I/Ii Non Treated

ClinConnect Summary

1. Introduction 1.1. Background: Breast cancer is one of the leading causes of death for women globally, according to the world health organization (WHO), the number of cancer cases expected in 2025 will be 19.3 million cases. In Egypt, cancer is an increasing problem and especially breast cancer \[1\].

Breast cancer is the most common female malignant tumor and a major threat to women's health and its development is considerably aggressive local invasion, early metastases, and multidrug resistance to chemotherapy \[2, 3\]. Therefore, developments of minimally-invasive markers for early...

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • • were being an adult female, with breast invasive carcinoma of no specific type, confirmed pathologically
  • Exclusion Criteria:
  • * Patients with:
  • • were blood disease, any cancer other than BC, liver cirrhosis, and uterine and urinary bladder diseases, or metastatic BC patients who received chemo/radiotherapy, or had previous mastectomy.

About Ain Shams University

Ain Shams University, established in Cairo, Egypt, is a prestigious higher education institution renowned for its commitment to academic excellence and research innovation. As a clinical trial sponsor, the university leverages its extensive resources and expertise in various medical and scientific disciplines to advance healthcare through rigorous research initiatives. With a focus on ethical practices and adherence to regulatory standards, Ain Shams University aims to contribute to the development of new therapies and improve patient outcomes, fostering collaboration among researchers, healthcare professionals, and industry partners in the pursuit of medical advancements.

Locations

Cairo, , Egypt

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0